Specifically, C5a correlates with secondary CVD events or restenosis in patients with coronary heart disease and peripheral artery disease [38–40], while circulating C5b-9 levels predict risk of death or functional outcome in patients with acute myocardial infarction and heart failure [41, 42]. This evidence concerns the gene C5 and myocardial infarction.